Drugs / V0034CR01B
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01467362 | Nov 2011 → May 2012 | atopic eczema | Pierre Fabre Laboratories | Completed | No outcome recorded |
| Phase 3 | NCT01084148 | Jan 2007 → Jan 2009 | — | Orfagen | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | V0034CR01B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01467362 ↗ |